Inhibition of platelet aggregation by prostacyclin is attenuated after exercise in patients with angina pectoris

This publication has 29 references indexed in Scilit:

• In vitro study of vascular endothelial injury by activated platelets and its prevention
  Atherosclerosis, 1989
• The role of prostacyclin during exercise in patients with chronic angina pectoris.
  Japanese Heart Journal, 1988
• Impaired cardiac PGI2 and PGE2 biosynthesis in patients with angina pectoris
  American Heart Journal, 1986
• Platelet prostacyclin binding in coronary artery disease
  Journal of the American College of Cardiology, 1986
• Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion.
  Circulation, 1985
• Plasma thromboxane B2, 6-KETO PGF1.ALPHA. and cyclic nucleotides levels as related to treadmill exercise test in patients with ischemic heart disease.
  Japanese Circulation Journal, 1985
• Sensitivity of platelets to prostaglandins in coronary heart disease and angina pectoris
  Prostaglandins, 1981
• The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK 36 374) ? Equipotent to PGI2 in vitro
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1981
• Platelet function studies in coronary heart disease. IX. Increased platelet prostaglandin generation and abnormal platelet sensitivity to prostacyclin and endoperoxide analog in angina pectoris
  The American Journal of Cardiology, 1980
• An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
  Nature, 1976